Use of ADT was associated with a decreased point estimate of any GAC (HR 0.64 [95% CI 0.37–1.09]), but it did not reach statistical significance.
← all excerpts
Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer.
1
—
—